Research Article
Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel
Figure 1
18F-FCH PET/CT images of a mCRPC patient (83 years old) with a PMD after docetaxel treatment. Baseline (a–c) and post-treatment (d–f) images. Maximum intensity projection images (a, d), transaxial slice of PET images (b, e), and PET/CT images (c, f) showing the prostate (arrows): pre-treatment SUVmax = 8.8 g/ml (c) and post-treatment SUVmax = 12.0 g/ml (f).
| (a) |
| (b) |
| (c) |
| (d) |
| (e) |
| (f) |